Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Regarding weight loss, the SURMOUNT-1 trial revealed meaningful results, with participants achieving body weight reductions of up to 20.9% when treated with 15 mg doses over 72 weeks [46]
January 21, 2025
This age-related decline is one of the most frequently cited data points in copper-peptide research literature, and its a primary reason GHK-Cu is studied within the broader context of cellular aging and peptides for longevity research rather than treated purely as a wound-healing or dermatology compound
Separate 12-week clinical studies by Leyden et al
US$ 21.05
US$ 28.31
US$ 22.24
US$ 25.46
